Apple Watch targets blood pressure 2026
- Apple Watch supplier chatter on May 20 pointed to a redesigned model in the second half of 2026 centered on blood-pressure sensing hardware. - DigiTimes-linked reporting says Taiwan-Asia Semiconductor could see large-volume sensor orders as early as July if Apple advances the redesigned watch. (macrumors.com) - Apple’s next widely cited health target after blood pressure remains noninvasive glucose monitoring, which outside reports still describe as years away. (macrumors.com)
Apple has not announced a 2026 Apple Watch redesign or a blood-pressure product roadmap. What exists so far is a mix of supply-chain reporting, prior Bloomberg reporting on Apple’s health ambitions, and a new social-media thread that sketches a more detailed timeline than any mainstream outlet has published. DigiTimes-based reporting published May 18 said a redesigned Apple Watch Ultra 4 could arrive in fall 2026 with blood-pressure monitoring, and that Taiwan-Asia Semiconductor, described there as Apple’s exclusive sensor-component supplier, could receive large-volume orders as early as July. (macrumors.com) The same report said the feature was under FDA review and described the redesign as a “full redesign” with a “significant upgrade to sensing functions.” ### What can actually be verified right now? MacRumors, citing DigiTimes on May 18, reported that Apple was preparing a redesigned Apple Watch Ultra 4 with a high-blood-pressure notification feature that uses the optical heart-rate sensor to analyze blood-vessel response to each heartbeat. That report also said market observers expected the sensor upgrade to benefit Taiwan-Asia Semiconductor and linked the launch to fall 2026. Bloomberg’s Mark Gurman said on March 26 that he did not expect major design changes for the next Apple Watch models coming later in 2026. (macrumors.com) That does not rule out a later 2026 product or a specific Ultra refresh, but it does show that the redesign timeline remains disputed across Apple-watchers. ### Is this the same as Apple giving exact blood-pressure readings? Bloomberg reported in November 2023 that Apple was working on a blood-pressure system for the watch that would first detect when a user’s blood pressure is elevated, rather than provide exact systolic and diastolic readings. (macrumors.com) That earlier description matches the direction of the newer DigiTimes-based report, which also describes a notification-style feature rather than a cuff replacement. MacRumors said the new system would use the optical heart sensor on the back of the watch to look for abnormal patterns in how blood vessels respond to each heartbeat. (macrumors.com) The publication also noted Apple already introduced Hypertension Notifications in watchOS 26 last fall, making the reported 2026 hardware upgrade look more like a more advanced or more clinically validated version of an existing direction, not a wholly new category. ### Where does the Serenity thread go further? The Serenity post goes beyond the mainstream reports by assigning a second-half 2026 window to blood-pressure hardware built around TASC photodiodes and by pushing noninvasive glucose monitoring into the second half of 2027 to 2028. (bloomberg.com) That level of supplier and revenue detail could not be independently verified from accessible source material in this review because the X post itself was not readable through the web tool, and no primary Apple filing or supplier disclosure surfaced to confirm those specifics. That means the thread is best treated as unconfirmed supply-chain analysis layered on top of a broader reporting base that Apple is pursuing blood-pressure and glucose-related health features. (macrumors.com) The broad direction is consistent with years of reporting; the exact component choices, supplier beneficiaries and dates are not yet independently confirmed here. ### How credible is the glucose part of the timeline? Apple’s glucose effort is real and long-running. Bloomberg reported in 2023 that Apple had placed one of Johny Srouji’s top silicon deputies, Tim Millet, over the noninvasive glucose project, and described the work as a chip-and-sensor system that uses lasers and algorithms. (x.com) But the launch timing remains uncertain. A January 2026 9to5Mac report said noninvasive glucose monitoring had been rumored for years and still had not arrived, while a March 2025 MacRumors item citing Bloomberg said the feature remained “many years away” from debuting on Apple Watch. (macrumors.com) That makes a 2027-2028 window plausible as rumor, but not verified as Apple’s plan. ### What should readers watch next? July is the first concrete date in the current reporting chain. The DigiTimes-based report says sensor orders for the redesigned watch could begin as early as July, which would be the next visible checkpoint for supplier signals. (9to5mac.com) Fall 2026 is the next product milestone. MacRumors said the redesigned Ultra 4 would be expected alongside Apple’s 2026 iPhone lineup, while Gurman’s March comments remain a counterweight against assuming a broad Apple Watch redesign is locked in. Until Apple files regulatory materials or introduces the product, the safest reading is narrower: blood-pressure notifications look closer than glucose, and the exact 2026-2028 hardware roadmap is still unconfirmed. (9to5mac.com) (macrumors.com)